Randomized, Crossover Pharmacodynamic Study Comparing the Effects of Zegerid (20 mg Omeprazole/Sodium Bicarbonate) and Prilosec OTC Tablets (20 mg-Equivalent Omeprazole).

Trial Profile

Randomized, Crossover Pharmacodynamic Study Comparing the Effects of Zegerid (20 mg Omeprazole/Sodium Bicarbonate) and Prilosec OTC Tablets (20 mg-Equivalent Omeprazole).

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Omeprazole/sodium bicarbonate (Primary) ; Omeprazole
  • Indications Duodenal ulcer; Dyspepsia; Erosive oesophagitis; Gastric cancer; Gastritis; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacodynamics; Registrational
  • Sponsors Bayer; Merck Sharp & Dohme; Schering-Plough
  • Most Recent Events

    • 20 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top